Dr. Nabeel Bardeesy is an Associate Professor of Medicine at Harvard Medical School and the Massachusetts General Hospital Cancer Center.

He is the recipient of the Gallagher Endowed Chair in Gastrointestinal Cancer Research. His lab focuses on the molecular pathways underlying the pathogenesis of pancreatic and biliary tract cancers.  His group has generated a series of genetically engineered mouse models of both of these malignancies to investigate the functional interactions between key gene mutations. His lab has an interest in the convergence of cell metabolism and epigenetics in control of cellular differentiation programs and tumor cell growth.  He is presently co-director of the Harvard Specialized Program in Research Excellence (SPORE) in gastrointestinal malignancies and serves as Director of the Scientific Advisory Board of the Cholangiocarcinoma Foundation. He earned in B.Sc. and Ph.D. in Biochemistry from McGill University in Montreal, Quebec, Canada, and did his postdoctoral training at the Dana-Farber Cancer Institute in Boston, Massachusetts.